The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Automation In Biopharma Industry Global Market Report 2023, The global automation in biopharma industry market is expected to grow from $1.82 billion in 2022 to $6.55 billion in 2023 at a compound annual growth rate (CAGR) of 6.5%. The automation in biopharma industry market is expected to reach $2.47 billion in 2027 at a CAGR of 6.2%.

What was the major driver in the automation in biopharma industry market?
The increasing adoption of robots in pharmaceutical manufacturing is expected to propel the growth of automation in biopharma industry market. Robots in pharmaceutical manufacturing refer to advanced automated systems and machines that perform various tasks in producing and packaging pharmaceutical products. Robots are often used in multiple applications in pharmaceutical manufacturing, such as secondary packaging, intralogistics, laboratory automation, pick and place, automation of pharmacy processes, and personalized medicine, resulting in greater productivity, enhanced precision, reduced risk of contamination, and improved worker safety. For instance, in December 2021, according to the Association for Advancing Automation (A3), a US-based industry association promoting and advancing automation technologies, the North American robotics market achieved remarkable growth, with 29,000 units ordered valued at $1.48 billion in Q3 2021, with an impressive 37% increase in units sold and 35% increase in value compared to 2020. Moreover, the application of robotics in the life sciences, pharmaceutical, and biomedical sectors saw a substantial 36% increase in the first nine months of 2021 compared to 2020. Therefore, the increasing adoption of robots in pharmaceutical manufacturing will drive the growth of automation in biopharma industry market.

View More On The Automation In Biopharma Industry Market Report 2023 – https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

What was the key trend in the automation in biopharma industry market?
Technological advancements are a key trend gaining popularity in the automation in biopharma industry market. Major companies operating in the automation in biopharma industry market are focused on developing advanced product technologies to strengthen their position in the market. For instance, in September 2022, PerkinElmer Inc., a US-based company providing scientific solutions and technologies, launched the Cellaca PLX Image Cytometry System, a cutting-edge automated cell analysis solution designed to simplify cell and gene therapy research and manufacturing. The Cellaca PLX platform allows researchers to evaluate critical quality attributes of cell samples, including identity, quantity, and quality, through an automated workflow. This integrated system combines image cytometer hardware, software, validated consumables, and trackable data reporting, simplifying calibration and training requirements.

Which was the largest region in the automation in biopharma industry market?
North America was the largest region in the automation in biopharma industry market in 2022. The regions covered in automation in biopharma industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the automation in biopharma industry market prominent players?
Major players in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, and BioTek Instruments Inc.

Key automation in biopharma industry market segments
The global automation in biopharma industry market is segmented –
1) By Technology: Automation Technology, Digitization Technology
2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase
3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Request A Sample Of The Global Automation In Biopharma Industry Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12704&type=smp

The Automation In Biopharma Industry Global Market Report 2023  provides a comprehensive overview on the automation in biopharma industry market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Biopharmaceuticals Contract Manufacturing Global Market Report 2023
Process Automation And Instrumentation Global Market Report 2023
Biopharmaceutical CMO Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
 LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model